Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma

X Xin Liu Z Zelong Liu C Chengzhan Zhu T Tatsuya Kobayashi P Pin-Ji Lei (Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School) Y Yue Shi (Department of Chemistry, School of Science) D Dandan Yuan (College of Pharmacy, Nanjing University of Chinese Medicine, No. 138, Xianlin Road, Nanjing, Jiangsu Province 210023, China) J Jianguo Wang (School of Chemistry and Chemical Engineering) M Min Li A Aya Matsui (Vollum Institute, Oregon Health and Science University) K Kassiana Mafra T Tomofumi Ando K Ken Kojo R Rieke Schleinhege K Kento Miyazaki P Peigen Huang (Department of Radiation Oncology, Edwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School) M Ming Kuang L Lloyd Bod D Dan G. Duda (Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School)